Small-bowel myeloid sarcoma: Report of a case with atypical presentation  by Girelli, Carlo M. et al.
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INTRODUCTION:  Small-bowel  myeloid  sarcoma  is  rare.  Acute  bowel  obstruction  is its usual  clinical  pre-
sentation.
PRESENTATION  OF  CASE:  We  report  a case  of small-bowel  myeloid  sarcoma  that  occurred  in  a  64-year-
old woman  who  presented  chronic  secretory  diarrhoea,  hypokalaemia,  and  weight  loss.  Immature  white
blood cells  in a peripheral  smear  and  small-bowel  capsule  endoscopic  features  were  the  main  diagnostic
clues.  The  patient  experienced  capsule  retention  and  developed  acute  bowel  obstruction.  Urgent  laparo-
tomy  showed  a stricturing  ileal  mass  and  pathology  of the  resected  bowel  specimen  unveiled  a CD34+,
CD117+,  and  myeloperoxidase-positive  myeloid  sarcoma.  The  diarrhoea  promptly  resolved  after  surgery,
and the  patient  is  now  undergoing  chemotherapy.
DISCUSSION:  Secretory  diarrhoea  can  be  the  ﬁrst manifestation  of small-bowel  myeloid  sarcoma.  Capsulemall-bowel endoscopy  may  provide  a diagnostic  clue,  but it can  trigger  an  acute  bowel  obstruction.  Differential
diagnosis  of the pathologic  specimen  may  be  difﬁcult  and  a high  suspicion  index  of  is mandatory  to
perform  immunophenotyping  to  determine  the  correct  management.
CONCLUSION:  Chronic  diarrhoea  with  alarm  features  can  be  the  ﬁrst  manifestation  of  small-bowel  myeloid
sarcoma.
© 2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Myeloid sarcoma (MS) is a rare malignant solid tumour com-
osed of myeloblasts and immature/aberrant myeloid cells located
utside the bone marrow.1 Generally, MS  predates the develop-
ent of acute myeloid leukaemia (AML), although MS  has been
eported simultaneous to haematologic malignancy or during a
elapse. Any organ or tissue can be affected by MS,  and multi-
ocal localisations have been reported.2 In the largest published
eries to date, the gastrointestinal tract was involved in only 6.5%
f cases, with a predilection for the small bowel.3 In this paper, we
eport an additional case of small-bowel MS  with atypical clinical
resentation.
Abbreviations: AML, acute myeloid leukaemia; MS,  myeloid sarcoma; SBCE,
mall bowel capsule endoscopy.
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Case report
A previously healthy 64-year-old woman  was admitted to our
gastrointestinal unit for unexplained chronic diarrhoea and a loss
of more than 10% of her usual body weight. Watery, non-bloody
diarrhoea had started six weeks before admission. Blood analyses
performed four weeks before admission showed mild normo-
cytic anaemia, low serum albumin, and hypokalaemia. Total serum
immunoglobulin A was normal. Anti-transglutaminase antibodies
were negative, along with stool examination (including culture
and a search for ova and parasites), oesophagogastroduodenoscopy
with duodenal biopsies, and ileocolonoscopy with biopsies per-
formed two  weeks before admission. The patient appeared pale
and thin, with dry skin and mucous membranes. Her abdomen was
ﬂat and soft, and deep palpation did not arouse pain or guard-
ing. Her liver and spleen were not felt, and bowel sounds were
present. A blood cell count showed 11.2 × 109/L white blood cells,
with 22% of immature cells in a peripheral smear. After ﬂuid and
lytes replacement, a bone marrow biopsy was performed, which
disclosed immature cells: namely, 30% of blasts, CD45+, CD34+,
CD117+, CD33+, CD13+, and HLADR+; normal karyotype (46XX);
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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rig. 1. Small-bowel capsule endoscopy frame showing a luminal stricture with
hickened mucosa and short, swollen villi.
LT3 0; and NPM: absence of mutations. A diagnosis of de novo
ML, FAB M1  was made. As chemotherapy was not possible due
o the persisting large volume of diarrhoea, small-bowel capsule
ndoscopy (SBCE) was performed (PillCam SB3, Given Imaging). One
our and twenty-two minutes after ingestion, the capsule did not
ig. 3. Histopathology of the resected bowel specimen. (A) Diffuse inﬁltration by round
ound  or oval folded nuclei containing dispersed chromatin and exhibited strongly positiFig. 2. Laparotomic ﬁnding of an annular, stricturing mass lesion of the ileum
(arrow).
pass through an ileal stricture next to the dilated lumen, ﬁlled with
luminal debris. The mucosa was  thickened and pale, with short
and swollen villi (Fig. 1). The following day, vomiting, abdominal
pain, and distension ensued, and abdominal CT disclosed a stric-
ture of the distal ileum next to the retained capsule, with proximal
bowel dilation. On the 10th day of the hospital stay, laparotomy
was performed. When the peritoneum was opened, a marked
enlargement of the small bowel adjacent to an annular stenosis,
15 cm proximal to the ileocaecal valve, was  found (Fig. 2). Seg-
mental ileal resection with manual latero-lateral anastomosis was
, small- to medium-sized cells with moderate basophilic cytoplasm. The cells had
ve staining for CD34 (B), CD117 (C), and myeloperoxidase (D).
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erformed. The still-ﬂashing capsule was retrieved within the
esected bowel. The postoperative course was uneventful, with
arly oral feeding, bowel canalisation, and full resolution of the
iarrhoea. Pathologic examination of the resected specimen dis-
losed diffuse inﬁltration by round, small- to medium-sized cells
ith moderate basophilic cytoplasm. The cells had round or oval
olded nuclei containing dispersed chromatin. The blastic features
ere compatible with very immature myeloid cells, and the cells
ere strongly positive for CD34, CD117, and myeloperoxidase, a
athologic picture diagnostic of MS  (Fig. 3). At the time of writing,
he patient was being treated with a combination of cytarabine
nd anthracyclines (3-plus-5 scheduled regimen), and stem cell
obilisation was obtained for eventual rescue treatment.
. Discussion
MS  is a tumour mass consisting of myeloid blasts occurring
t an anatomical site other than the bone marrow. Inﬁltration
f any site in the body by myeloid blasts in leukemic patients
s not considered as MS  unless it presents with tumour masses
n which the tissue architecture is effaced. In the past, the gross
reenish appearance that occasionally characterised this curious
eoplasm was given the name “chloroma.” It is a rare condition;
ess than 1% of patients with AML  will present with MS.4 MS
ost commonly consists of myeloblasts with or without features
f promyelocytic or neutrophilic maturation. In a signiﬁcant pro-
ortion of cases, MS  displays myelomonocytic or pure monoblastic
orphology. Regarding immunohistochemistry, MS  has been well
haracterised, with CD68/KP1 being the most commonly expressed
arker, followed by, in order of decreasing frequency, MPO,
D117, CD99, CD68/PG-M1, lysozyme, CD34, TdT, CD56, CD61,
D30, glycophorin, and CD4.3 Although a variety of chromosomal
bnormalities have been reported in 55% of cases, none of these
lterations was found in our patient. Any organ system may  be
nvolved in MS,  although the skin, soft tissues, and nodes account
or up to half of all localisations. MS  of the gastrointestinal tract
s reported in 6.5% of cases3 at any site from the mouth to the
nal verge, but this sarcoma seems to have a predilection for the
mall bowel, as other neoplasms with elevated haematogenous
pread, such as melanoma and lung cancer. The reason for this
mall-bowel tropism is unclear, but it may  be due to the large
ascular and lymphatic supplies of the absorptive portion of the
astrointestinal tract. A unique feature of this case is the clinical
resentation with chronic diarrhoea and weight loss and without
bdominal pain or obstructive symptoms. In a literature review per-
ormed by Kohl and co-workers, none of the 19 patients diagnosed
ith small-bowel MS  had the same clinical presentation.5 From a
athophysiologic standpoint, in experimental animals, mechanical
owel wall stimulation, such as mucosal stroking and distension
f the intestine, initiates luminal chloride secretion by myen-
eric and submucosal neural mechanisms; thereafter, the release
f vasoactive compounds such as VIP may  mediate hypersecre-
ion and splanchnic vasodilation, as demonstrated in an elegant
experimental canine model of partial small-bowel obstruction.6
Differential diagnosis of the pathologic specimen may  be difﬁcult,
particularly in the case of lymphoblastic, Burkitt’s, or diffuse large
B-cell lymphoma or even a non-haematologic malignancy,1 and a
high suspicion index of MS  is mandatory to perform immunophe-
notyping to determine the correct management. Finally, we will
make a short comment on the use of SBCE to investigate the unex-
plained diarrhoea of our patient. As outlined in a recent review
article, SBCE is considered to be appropriate in the clinical set-
ting of chronic diarrhoea associated with at least one “red-ﬂag”
symptom (weight loss, anaemia, and increased C-reactive pro-
tein levels).7 In the largest unselected, multicentre, prospective
study of SBCE, chronic diarrhoea was the indication in 140 of
2921 (4.8%) consecutive examinations, and SBCE was  diagnostic
and retained in 39 (27.8%) and 2 (1.4%) cases, respectively.8 Our
patient developed acute intestinal obstruction after capsule reten-
tion, representing the 0.07% in the quoted series. Furthermore, to
the best of our knowledge, no SBCE image of small-bowel MS  has
been previously published. Interestingly, using retrograde double-
balloon enteroscopy, Hotta and Kunieda recently described the
endoscopic picture of ileal MS,  consisting of swollen villi of dif-
ferent sizes and mucosal thickening, a picture overlapping with
the SBCE ﬁndings of our patient.9 In conclusion, we  reported an
additional case of small-bowel MS  presenting with chronic diar-
rhoea and weight loss, and, for the ﬁrst time, we  showed the
SBCE ﬁndings of this rare tumour. Although our patient experi-
enced a complication of SBCE, mandating surgery, her diarrhoea
resolved after tumour resection, and chemotherapy was  ultimately
feasible.
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Key learning points
• Small-bowel myeloid sarcoma can be the ﬁrst presentation of acute leukaemia.
• Chronic diarrhoea and weight loss can be the only symptoms of small-bowel myeloid sarcoma.
• Capsule endoscopy may  provide a diagnostic clue, but it can trigger an acute bowel occlusion.
• To address the right treatment, high suspicion index is param
the pathological specimen.
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